| Schedule of Segment Reporting Information, by Segment |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Clinical studies | 10,130 | | | 12,929 | | | 33,190 | | | 34,157 | | | BLA & Regulatory | 3,296 | | | 2,031 | | | 6,979 | | | 5,121 | | | Medical Affairs & Other Medical | 2,256 | | | 2,156 | | | 6,223 | | | 6,446 | | | Research & Innovation | 364 | | | 322 | | | 1,450 | | | 1,087 | | | Manufacturing & Supply and Quality | 12,569 | | | 6,224 | | | 35,948 | | | 23,627 | | | Sales & Marketing | 1,178 | | | 519 | | | 1,859 | | | 2,263 | | | General & Administrative | 7,259 | | | 7,220 | | | 21,348 | | | 23,667 | | | Total expenses | 37,051 | | | 31,401 | | | 106,997 | | | 96,368 | |
|